Market Cap

Strongbridge Biopharma plc Market Capitalization:

$135.7 Million

USD as of Oct. 1, 2021

business Strongbridge Biopharma plc Company Profile

Strongbridge Biopharma plc Main Stock Listing

NASDAQ: SBBP

Market Capitalization History of Strongbridge Biopharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Strongbridge Biopharma plc market cap

Date Market Cap YoY Change

Market capitalization is calculated from the opening stock price at the beginning of each year.

Strongbridge Biopharma plc Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Strongbridge Biopharma plc has the following listings and related stock indices.


Stock: NASDAQ: SBBP

Stock: FSX: 69BN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.